Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of Ceradyne, Inc. (“Ceradyne” or the “Company”) (NASDAQ: CRDN) (ISIN: US1567101050) concerning the proposed acquisition of Ceradyne by 3M in a cash transaction valued at approximately $860 million. The investigation concerns whether the Ceradyne directors are breaching their fiduciary duties by failing to adequately shop the Company and maximize shareholder value. Under the terms of the agreement, Ceradyne shareholders would receive $35.00 in cash per share of Ceradyne common stock. However, Ceradyne stock traded above the offered price in the past year. Ceradyne shareholders seeking more information about this acquisition are advised to contact Samuel J. Adams at email@example.com or 212-661-1100 or 888-476-6529, ext. 300. The Pomerantz Firm, with offices in New York, Chicago and San Diego, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 75 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of defrauded investors. See www.pomerantzlaw.com.